Human models of NUP98-KDM5A megakaryocytic leukemia in mice contribute to uncovering new biomarkers and therapeutic vulnerabilities. (Record no. 30284834)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02313 a2200685 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250518070102.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 202009s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 2473-9537 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1182/bloodadvances.2019030981 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Cardin, Sophie |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20200901 |
| 245 00 - TITLE STATEMENT | |
| Title | Human models of NUP98-KDM5A megakaryocytic leukemia in mice contribute to uncovering new biomarkers and therapeutic vulnerabilities. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Blood advances |
| Date of publication, distribution, etc. | 11 2019 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 3307-3321 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Journal Article; Research Support, Non-U.S. Gov't |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Animals |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Biomarkers |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Biomarkers, Tumor |
| General subdivision | genetics |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Computational Biology |
| General subdivision | methods |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Disease Models, Animal |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Disease Susceptibility |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Gene Expression |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Gene Expression Profiling |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | High-Throughput Nucleotide Sequencing |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Immunophenotyping |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Leukemia, Megakaryoblastic, Acute |
| General subdivision | etiology |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Mice |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Neoplastic Stem Cells |
| General subdivision | metabolism |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Nuclear Pore Complex Proteins |
| General subdivision | genetics |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Oncogene Proteins, Fusion |
| General subdivision | genetics |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Retinoblastoma-Binding Protein 2 |
| General subdivision | genetics |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Xenograft Model Antitumor Assays |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Bilodeau, Mélanie |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Roussy, Mathieu |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Aubert, Léo |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Milan, Thomas |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Jouan, Loubna |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Rouette, Alexandre |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Laramée, Louise |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Gendron, Patrick |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Duchaine, Jean |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Decaluwe, Hélène |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Spinella, Jean-François |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Mourad, Stéphanie |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Couture, Françoise |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Sinnett, Daniel |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Haddad, Élie |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Landry, Josette-Renée |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Ma, Jing |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Humphries, R Keith |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Roux, Philippe P |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Hébert, Josée |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Gruber, Tanja A |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Wilhelm, Brian T |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Cellot, Sonia |
| 773 0# - HOST ITEM ENTRY | |
| Title | Blood advances |
| Related parts | vol. 3 |
| -- | no. 21 |
| -- | p. 3307-3321 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1182/bloodadvances.2019030981">https://doi.org/10.1182/bloodadvances.2019030981</a> |
| Public note | Available from publisher's website |
No items available.